Light reveals breast tumor oxygen status

April 01, 2009

DURHAM, N.C. - Light directed at a breast tumor through a needle can provide pathologists with biological specifics of the tumor and help oncologists choose treatment options that would be most effective for that individual patient.

Duke University bioengineers have developed a light-based system that can quickly and easily provide important information about oxygen levels within a tumor while it is still in place. The new system, based on diffuse reflectance spectroscopy, gives researchers important clues about the tumor by interpreting how the light is either reflected back from the tumor or absorbed.

Oxygen status is important, the researchers said, since past studies have shown that low levels of oxygen, or hypoxia, are more often associated with malignant tissue than healthy normal tissue. Tumors that thrive in these low-oxygen environments tend to be more difficult to treat, the researchers said.

"We developed an easy-to-use fiber-optic probe that can provide immediate and non-destructive measurements of tumor oxygenation," said J. Quincy Brown, a fourth-year post-doctoral fellow in the laboratory of Nirmala Ramanujam, associate professor of biomedical engineering at Duke's Pratt School of Engineering. The results of the Duke experiments were published April 1 in the journal Cancer Research.

"This new approach could be an important new tool for physicians in determining the aggressiveness of a specific tumor and which therapies might work best against it," Brown said. "Since this system is compatible with commonly used biopsy needles, we could make oxygen measurements at the time of a needle biopsy, providing immediate feedback about the tumor's oxygen concentration."

In their current experiments, the researchers enrolled 35 women who were to undergo surgery for their breast cancer. Before the surgery, the researchers directed normal, UV-visible light directly through a needle at the surface of the tumor while it was still in the breast. Since the system gathers information immediately, researchers are able to take readings at multiple locations in little time.

Their main target was blood and its hemoglobin, a protein which is responsible for carrying oxygen throughout the body, as well as to tumors. While some types of breast cancer thrive in environments low in oxygen, other cancers stimulate the growth of new blood vessels to feed oxygen to the tumor.

"Our system measured how the light was either absorbed by the hemoglobin, which gave us an optical fingerprint of the oxygen status of the tumor," Brown explained. "This fingerprint can give clues about which form of therapy - chemo, radiation, surgery - might be the most effective for that particular tumor."

One interesting finding involved tumors with the gene HER2/neu. It is estimated that one in five breast cancers exhibit over-expression of the HER2/neu gene. A routinely used drug known as Herceptin, which can block HER2/neu over-expression, is only effective in treating tumors with this gene.

"The tumors that over-expressed the HER2/neu gene had significantly higher levels of oxygen," Brown said. "This is likely due to the fact that the amplification of this gene encourages the formation of tiny new blood vessels, which in turn feed the tumor. Knowing how the Her2/neu status of a tumor is affecting tumor oxygenation at the time of biopsy would be useful information for the oncologist, since over-expression of this gene typically leads to a cancer that is more aggressive and more resistant to treatment."

The researchers plan future studies of breast cancer patients undergoing chemotherapy by taking regular oxygen measurements to determine how a particular tumor is responding to therapy over time.

Duke University

Humor After the Tumor: One Woman's Look at Her Year With Breast Cancer
by Patty Gelman (Author), Leslie Zemsky (Illustrator)

Breast cancer survivor Patty Gelman recounts her journey through "Cancer World" in a series of anecdotes, chronicling her year-long struggle with the disease in an upbeat, colloquial, and often candidly funny way. Typical of her unyieldingly positive attitude is the way that Gelman breaks the news to her mother, also a cancer survivor: "Well, it's my turn now!"

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research)
by Michail Ignatiadis (Editor), Christos Sotiriou (Editor), Klaus Pantel (Editor)

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs...

Magnetic Resonance Spectroscopy of Breast Tumors
by Gary M. Tse (Editor), Humairah Samad Cheung (Editor), Jingfei Ma (Editor)

This book aims to provide a basic understanding of the principles of in vivo Magnetic Resonance Spectroscopy (MRS), a pioneer technique which is now finding increasing clinical uses in detection of cancer in a non-invasive manner and provide a comprehensive evaluation and assessment of the current status of MRS in the field of breast tumor detection. It also provides an updated, concise review on breast tumor pathology and MR imaging. It offers some introduction into the in vitro MRS and other future potential diagnostics in the field of breast tumours.

Mastopexy and Breast Reduction: Principles and Practice
by Melvin A. Shiffman (Editor)

This comprehensive guide covers all aspects of mastopexy and breast reduction, ranging from anatomy to the variety of procedures in mastopexy, mastopexy/breast reduction, and breast reduction, preoperative care, complications, breast tumors (benign and malignant), and medicolegal aspects.

A Color Atlas of Breast Histopathology
by M. Trojani (Author)

Tumors of the Breast: Based on the Proceedings of the 53rd Annual Anatomic Pathology Slide Seminar of the American Society of Clinical Pathologists (Anatomic Pathology Slide Seminar//(Proceedings))
by La.) Anatomic Pathology Slide Seminar 1987 (New Orleans (Author), Harold A., M.D. Oberman (Author), William R. Hart (Author), Paul Peter Rosen (Author), American Society of Clinical Pathologists (Corporate Author)

Tumor Suppressor Genes in Breast Cancer
by Marc Lacroix (Editor)

Breast cancer is characterised by the accumulation of genetic alterations, including point mutations and loss of entire DNA regions ("loss of heterozygosity" or LOH). Among genes that are affected by such events, the "tumour suppresser genes" (TSGs) have a peculiar interest since they often occupy pivotal positions in regulatory networks that control the cell cycle and/or encompass various signal transduction cascades. While a number of genes have been suggested as candidate TSGs in breast cancer, only a few of them have been confirmed in this status. They include TP53, BRCA1, BRCA2 and are mainly involved in the control of DNA repair, cell proliferation, apoptosis and signalling. Some TSGs are linked to familial (hereditary) forms of breast cancer. The exact definition of what is a TSG...

Treatment of Breast Tumors
by Robert S. Pollack (Author)

Dr. Susan Love's Breast Book, 5th Edition (A Merloyd Lawrence Book)
by Susan M. Love MD (Author), Karen Lindsey (Contributor)

Dr. Susan Love’s Breast Book has long been the bible for the newly diagnosed. In this completely revised fifth edition, it also becomes a guide for those at risk of getting breast cancer, survivors interested in the consequences of their treatment, and anyone who wants to understand the new research about how the local environment influences the manifestations and treatments of many different kinds of breast cancer. Major advances being made in genetic research today mean that prevention and treatment can work not only to get rid of mutated cells (through chemo or surgery), but also to change the environment around the cells (through hormone therapy, exercise, and stress reduction). Among other promising developments discussed are advances in imaging, recognition of breast density as a...